Early Exclusive Enteral Nutrition in Early Preterm Infants

Status Recruiting

Clinical Trial Summary

Enteral nutrition in preterm infants is usually started and advanced slowly until reaching full enteral feeds. Most preterm infants born before 34 weeks gestation require parenteral fluids to maintain normal blood sugar level and prevent excessive weight loss and dehydration. Availability of donor human milk (DHM) along with low incidence of necrotizing enterocolitis (NEC) in preterm infants born at 30-33 weeks have encouraged neonatologists to start feeding early and advance it faster in order to shorten time on parenteral nutrition (PN) and minimize the need for intravenous access. The objectives of this trial is to study whether exclusive enteral nutrition from day of birth (i.e. no PN) results in shorter time to achieve full enteral feed when compared with traditional feeding regimen that involves a combination of PN and progressive enteral feeding.

Clinical Trial Description

Early nutritional support of preterm infants born at 30-33 weeks gestation is usually achieved via a combination of parenteral nutrition (PN) and enteral feeding that is advanced over few days to reach full enteral feed. Recent studies suggest that rapid increase of enteral feed volumes results in shorter duration on PN and earlier achievement of full enteral feed without increasing the risk of necrotizing enterocolitis (NEC) or death. Although PN has an important role in nutrition of preterm infants, it is associated with increased risk of metabolic and infectious complications even when it is used for a short period of time. Furthermore, PN mandates the need for peripheral or central intravenous access. Provision of full enteral feed volume that meets reference daily fluid intake from day of birth is used frequently and successfully in stable preterm infants born after 33 weeks. Expanding the use of this regimen to stable preterm infants born at 30-33 weeks gestation may help avoid unnecessary start of intravenous access, prevent complications related to PN, and encourage mother-infant bonding experience. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03708068
Study type	Interventional
Source	University of Calgary
Contact	Belal Alshaikh, MD
Phone	403-956-1588
Email	balshaik@ucalgary.ca
Status	Recruiting
Phase	N/A
Start date	April 16, 2019
Completion date	November 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02913677` - Prolonged Minimal Enteral Nutrition Versus Slowly Advancing Enteral Nutrition in Very Low Birth Weight Infants:	N/A
Not yet recruiting	`NCT00916591` - Prokinetic Drugs and Enteral Nutrition	N/A
Completed	`NCT01025167` - The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients	N/A
Not yet recruiting	`NCT05900323` - Enteral Nutrition Guidelines and Patients' Outcomes	N/A
Completed	`NCT03153397` - Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)	N/A
Completed	`NCT02353689` - The Effect of FODMAP Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement	Phase 2/Phase 3
Terminated	`NCT00564655` - Regional Anesthesia Block of the Transversus Abdominis Plane in Children Undergoing Gastric Tube Insertion	Phase 3
Completed	`NCT06134674` - Early Versus Delayed Enteral Nutrition in Critically Ill Adults With COVID-19
Recruiting	`NCT03791866` - The Th9/IL-9 and Early Enteral Nutrition in Sepsis	N/A
Enrolling by invitation	`NCT06161350` - The Multi-disciplinary Approach of Children With Feeding Difficulties and Tube Feeding in UZB Between 2000 and 2021
Active, not recruiting	`NCT02724631` - TubeClear® Evaluation in Pediatric Patients (Phase I)	N/A
Completed	`NCT01988792` - Human Milk Fortification in Very Low Birth Neonates	N/A
Completed	`NCT00600678` - Gastric Emptying Study After Administration of a High Caloric Sip Feed	N/A
Completed	`NCT02998931` - Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients	Phase 3
Recruiting	`NCT03176875` - Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's Disease	N/A
Completed	`NCT02779335` - Enteral Formula Tolerance in Pediatric Patients	N/A
Completed	`NCT05411848` - 2kcal Tube Feed Study	N/A
Completed	`NCT04868318` - The Impact of Intervention With High-protein Enteral Formula in SICU.	N/A
Not yet recruiting	`NCT04601571` - Confirming Feeding Tube Position Using CORTRAK	N/A
Not yet recruiting	`NCT06239610` - DrIFT 2 Study: Displacement in Feeding Tubes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.